Medicare Enrolled
Dr. Ferdy Santiago, MD
Hematology · Naples, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Santiago from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Santiago? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Santiago
Dr. Ferdy Santiago is a hematology in Naples, FL, with 16 years in practice. Based on federal Medicare data, Dr. Santiago performed 238,802 Medicare services across 4,736 unique beneficiaries.
Between the years covered by Open Payments, Dr. Santiago received a total of $9,284 from 74 pharmaceutical and/or device companies across 433 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Santiago is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice▲ Top 14% volume in FL$ $9,284 industry payments
Medicare Practice Summary
Medicare Utilization ↗238,802
Medicare services
Top 14% in FL for hematology
4,736
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~14,925 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 100,980 | $0 | $4 |
| Azacitidine chemotherapy injection | 20,681 | $0 | $4 |
| Pembrolizumab injection (Keytruda) | 16,800 | $43 | $137 |
| Anti-nausea injection (aprepitant) | 16,770 | $1 | $5 |
| Filgrastim injection (Zarxio) for white blood cells | 13,080 | $0 | $2 |
| Denosumab injection (Prolia/Xgeva) | 12,420 | $18 | $51 |
| Daratumumab injection (Darzalex) | 11,160 | $38 | $110 |
| Paclitaxel chemotherapy injection | 9,246 | $0 | $2 |
| Epoetin alfa injection (Procrit) for anemia | 8,600 | $6 | $23 |
| Iron sucrose injection (Venofer) | 5,700 | $0 | $5 |
| Blood draw (venipuncture) | 2,661 | $8 | $9 |
| Complete blood count (CBC) with differential | 2,659 | $8 | $29 |
| Dexamethasone injection (steroid) | 2,608 | $0 | $3 |
| Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 2,360 | $22 | $185 |
| Immune globulin infusion (Gammagard) | 2,304 | $36 | $108 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,740 | $1 | $28 |
| Office visit, established patient (20-29 min) | 999 | $69 | $239 |
| Drug injection, under skin or into muscle | 976 | $11 | $69 |
| Anti-nausea injection (ondansetron/Zofran) | 872 | $0 | $9 |
| Office visit, established patient (30-39 min) | 776 | $101 | $339 |
| Injection, leucovorin calcium, per 50 mg | 695 | $3 | $12 |
| Injection of additional new drug or substance into vein | 567 | $12 | $61 |
| Administration of chemotherapy into vein, 1 hour or less | 562 | $104 | $378 |
| Injection, fluorouracil, 500 mg | 447 | $2 | $7 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 421 | $1 | $6 |
| Injection, carboplatin, 50 mg | 392 | $2 | $41 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 302 | $23 | $84 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 247 | $57 | $206 |
| Administration of chemotherapy into vein, each additional hour | 212 | $23 | $79 |
| Injection, diphenhydramine hcl, up to 50 mg | 194 | $1 | $3 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 191 | $49 | $189 |
| Administration of additional new drug or substance into vein, 1 hour or less | 138 | $52 | $178 |
| Injection of drug or substance into vein | 127 | $29 | $156 |
| New patient office visit (30-44 min) | 126 | $89 | $298 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 112 | $17 | $59 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 83 | $16 | $56 |
| Infusion, normal saline solution , 1000 cc | 75 | $2 | $7 |
| Drawing of blood for a medical problem | 73 | $72 | $277 |
| Infusion into a vein for hydration, 31-60 minutes | 60 | $25 | $156 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 50 | $1 | $7 |
| Automated urinalysis | 48 | $2 | $8 |
| Infusion into a vein for hydration, each additional hour | 46 | $10 | $42 |
| New patient office visit (45-59 min) | 44 | $132 | $453 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 43 | $137 | $637 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 38 | $16 | $56 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 38 | $27 | $89 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 34 | $3 | $11 |
| Red blood count automated, with additional calculations | 28 | $5 | $20 |
| Red blood count, automated test | 17 | $4 | $10 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
43.6% high complexity
53.2% medium
3.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,284
Total received (2018-2024)
Avg $1,326/year across 7 years
Top 45% in FL for hematology
74
Companies
433
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,272 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$12 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,042
2023$1,051
2022$1,447
2021$799
2020$485
2019$1,812
2018$1,648
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$692
PFIZER INC.
$581
Celgene Corporation
$551
Merck Sharp & Dohme Corporation
$496
Janssen Biotech, Inc.
$476
Novartis Pharmaceuticals Corporation
$447
AstraZeneca Pharmaceuticals LP
$432
Amgen Inc.
$362
Fennec Pharmaceuticals, Inc.
$333
Genentech USA, Inc.
$289
Astellas Pharma US Inc
$284
Incyte Corporation
$282
AbbVie, Inc.
$202
Seagen Inc.
$176
Merck Sharp & Dohme LLC
$166
Daiichi Sankyo Inc.
$149
Takeda Pharmaceuticals U.S.A., Inc.
$146
ABBVIE INC.
$144
Lilly USA, LLC
$140
Bayer HealthCare Pharmaceuticals Inc.
$139
Rigel Pharmaceuticals, Inc.
$135
Gilead Sciences, Inc.
$126
TESARO, Inc.
$125
Janssen Scientific Affairs, LLC
$120
Octapharma USA, Inc.
$119
TAIHO ONCOLOGY, INC.
$114
GlaxoSmithKline, LLC.
$111
ARRAY BIOPHARMA INC
$109
Regeneron Healthcare Solutions, Inc.
$106
Intuitive Surgical, Inc.
$96
Medtronic USA, Inc.
$90
BeiGene USA, Inc.
$86
Stemline Therapeutics Inc.
$85
GENZYME CORPORATION
$77
Foundation Medicine, Inc.
$76
Kite Pharma, Inc.
$75
Myriad Genetic Laboratories, Inc.
$68
TerSera Therapeutics LLC
$67
Pharmacosmos Therapeutics Inc.
$65
AbbVie Inc.
$55
ADC Therapeutics America, Inc.
$54
Sumitomo Pharma America, Inc.
$53
Bayer Healthcare Pharmaceuticals Inc.
$53
Exelixis Inc.
$50
Heron Therapeutics, Inc.
$46
Eisai Inc.
$46
Janssen Pharmaceuticals, Inc
$36
JAZZ PHARMACEUTICALS INC.
$35
Dendreon Pharmaceuticals LLC
$31
Blueprint Medicines Corporation
$31
Boehringer Ingelheim Pharmaceuticals, Inc.
$30
Teva Pharmaceuticals USA, Inc.
$28
Puma Biotechnology, Inc.
$27
SOBI, INC
$27
Genmab U.S., Inc.
$25
Pharmacyclics LLC, An AbbVie Company
$25
Mirati Therapeutics, Inc.
$25
Pharmacyclics LLC, an AbbVie Company
$23
SERVIER PHARMACEUTICALS LLC
$22
Alexion Pharmaceuticals, Inc.
$22
Seattle Genetics, Inc.
$21
EMD Serono, Inc.
$19
Alnylam Pharmaceuticals Inc.
$19
PharmaEssentia USA Corporation
$18
GE HEALTHCARE
$17
Aurobindo Pharma USA, Inc.
$15
Veracyte, Inc.
$15
Dova Pharmaceuticals
$14
Myovant Sciences Inc.
$13
NanoString Technologies, Inc.
$13
Acrotech Biopharma LLC
$13
SANOFI-AVENTIS U.S. LLC
$12
SECURA BIO, INC.
$10
Secura Bio, Inc.
$4
Top 3 companies account for 19.6% of total payments
Associated products mentioned in payments ›
ADCETRIS · ALIMTA · AYVAKIT · Abraxane · Alecensa · Avastin · BENDEKA · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · CABLIVI · CABOMETYX · CALQUENCE · CERDELGA · CEREZYME · CINVANTI · COPIKTRA · COSELA · Cabometyx · DARZALEX · DOPTELET · Da Vinci Surgical System · Doptelet · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · ERLEADA · EVENITY · Enhertu · Epkinly · Erleada · FOUNDATIONONE · FRUZAQLA · Farydak · GAZYVA · GILOTRIF · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Intact · JAKAFI · JEMPERLI · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LENVIMA · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUTATHERA · LYNPARZA · Lenvima · Lunsumio · MARQIBO · MEKINIST · MONJUVI · MONOFERRIC · MYRISK · NINLARO · NUWIQ · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OJJAARA · ONPATTRO · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Orserdu · PADCEV · PEMAZYRE · PLUVICTO · PROMACTA · PROSIGNA ASSAY · PROVENGE · Padcev · Pedmark · Perjeta · Phesgo · Pomalyst · Prolia · REBLOZYL · Revlimid · SARCLISA · SPRYCEL · Stivarga · TAGRISSO · TASIGNA · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · VONVENDI · VOTRIENT · Venclexta · WILATE · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XALKORI · XARELTO · XOSPATA · XTANDI · Xofigo · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · ZYTIGA · Zevalin · Zoladex · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $4 per 100 Medicare services performed
Geographic Context
Hematologys within 10 mi
11
Per 100K population
2.8
County median income
$86,173
Nearest hospital
NAPLES COMMUNITY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Santiago is a mixed practice specialist, with above-average Medicare volume (top 14% in FL), and low-engagement industry engagement, with 16 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Santiago experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Santiago performed 100,980 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Santiago receive payments from pharmaceutical companies?
Yes. Dr. Santiago received a total of $9,284 from 74 companies across 433 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Santiago's costs compare to other hematologys in Naples?
Dr. Santiago's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Santiago) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologys in Naples
Browse hematologys in Naples ranked by procedure volume and transparency data.
Highest volume
Top Hematologys in FL
Hematologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologys in FL
Which FL hematologys receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C..
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology